CareDx (CDNA) director Fred E. Cohen receives 9,795-share RSU grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Cohen Fred E reported acquisition or exercise transactions in this Form 4 filing.

CareDx, Inc. director Fred E. Cohen received an equity grant of 9,795 shares of Common Stock in the form of restricted stock units. These RSUs vest 100% on the earlier of one year from the grant date or the day before the first Annual Meeting after the grant date, subject to his continuous service. Following this award, he holds 165,060 shares directly.

Insider Trade Summary 10b5-1

1 transaction reported

Mixed 1 txn

Insider Cohen Fred E

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,795	$0.00	--

Holdings After Transaction: Common Stock — 165,060 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSU grant size: 9,795 shares Price per share: $0.0000 per share Holdings after transaction: 165,060 shares +1 more

4 metrics

RSU grant size 9,795 shares Restricted stock units awarded to director on grant date

Price per share $0.0000 per share Equity grant issued at no cash cost

Holdings after transaction 165,060 shares Total direct Common Stock holdings after RSU grant

Vesting schedule 100% cliff vest Earlier of one year from grant or day before first Annual Meeting

Key Terms

restricted stock units, RSUs, Annual Meeting

3 terms

restricted stock units financial

"The reported securities are represented by restricted stock units ("RSUs")"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"The reported securities are represented by restricted stock units ("RSUs")"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Annual Meeting financial

"on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/16/2026 - 05:49 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cohen Fred E

(Last)

(First)

(Middle)

C/O CAREDX, INC.

8000 MARINA BOULEVARD, 4TH FLOOR

(Street)

BRISBANE

CALIFORNIA

94005

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/12/2026		A		9,795⁽¹⁾	A	$0	165,060	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.

	/s/ Jeffrey Adam Novack, Attorney-in-Fact	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did CareDx (CDNA) report for Fred E. Cohen?

CareDx reported that director Fred E. Cohen received a grant of 9,795 restricted stock units. These units represent Common Stock and were awarded at no cash cost as part of his equity compensation.

How many CareDx (CDNA) shares does Fred E. Cohen hold after this grant?

After the restricted stock unit grant, Fred E. Cohen holds 165,060 shares of CareDx Common Stock directly. This figure includes the newly awarded 9,795 RSUs, which convert into shares upon vesting under the stated conditions.

What are the vesting terms of Fred E. Cohen’s new RSUs at CareDx (CDNA)?

The 9,795 restricted stock units vest 100% on the earlier of the one-year anniversary of the grant date or the day immediately before the first Annual Meeting after the grant. Vesting requires his continuous service through the applicable vesting date.

Did Fred E. Cohen pay for the newly acquired CareDx (CDNA) shares?

No cash was paid for these shares. The Form 4 shows a price per share of $0.0000, indicating the 9,795 shares were granted as compensation through restricted stock units rather than purchased in the open market.

Is Fred E. Cohen’s CareDx (CDNA) transaction a market buy or sell?

The transaction is a grant or award acquisition, not a market buy or sell. It is coded as an “A” transaction, reflecting equity compensation in restricted stock units rather than an open-market trade.